WIGZELL HANS LENNART RUDOLF sold 39.6% of their position (15K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.85M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/11/2024ACC: 0000950170-24-029536
Director
Since Nov 2018
-15K
Net shares
Net seller
$1.85M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+15K
Price / share
$13.90
Trade value
$208.50K
% of position
65.7%
3/8/2024
22.84K→37.84K
Common Stock
Direct
Shares
−3.15K
Price / share
$123.85
Trade value
$390.75K
% of position
8.3%
3/8/2024
37.84K→34.69K
Common Stock
Direct
Shares
−11.74K
Price / share
$123.10
Trade value
$1.45M
% of position
33.9%
3/8/2024
34.69K→22.94K
Common Stock
Direct
Shares
−100.00
Price / share
$122.39
Trade value
$12.24K
% of position
0.4%
3/8/2024
22.94K→22.84K
Total
Net shares
+0.00
Net value
-$1.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/8/2024 | M · Option Exercise | +15K | $13.90 | $208.50K | 65.7% | 22.84K | 37.84K |
| Common Stock Direct | 3/8/2024 | S · Sale | −3.15K | $123.85 | $390.75K | 8.3% | 37.84K | 34.69K |
| Common Stock Direct | 3/8/2024 | S · Sale | −11.74K | $123.10 | $1.45M | 33.9% | 34.69K | 22.94K |
| Common Stock Direct | 3/8/2024 | S · Sale | −100.00 | $122.39 | $12.24K | 0.4% | 22.94K | 22.84K |
| Total | +0.00 | -$1.64M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
13.90
Held after
0.00
Exercisable
—
3/8/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15K shares | 3/8/2024 | M · Option Exercise | −15K | 13.90 | — | 0.00 |